Najafian, B., Tøndel, C., Svarstad, E., Sokolovkiy, A., Smith, K., & Mauer, M. (2016). One Year of Enzyme Replacement Therapy Reduces Globotriaosylceramide Inclusions in Podocytes in Male Adult Patients with Fabry Disease. PLoS One.
シカゴスタイル引用形Najafian, Behzad, Camilla Tøndel, Einar Svarstad, Alexey Sokolovkiy, Kelly Smith, , Michael Mauer. "One Year of Enzyme Replacement Therapy Reduces Globotriaosylceramide Inclusions in Podocytes in Male Adult Patients With Fabry Disease." PLoS One 2016.
MLA引用形式Najafian, Behzad, et al. "One Year of Enzyme Replacement Therapy Reduces Globotriaosylceramide Inclusions in Podocytes in Male Adult Patients With Fabry Disease." PLoS One 2016.
警告: この引用は必ずしも正確ではありません.